Equities

Avadel Pharmaceuticals PLC

Avadel Pharmaceuticals PLC

Actions
  • Price (USD)2.22
  • Today's Change0.150 / 7.25%
  • Shares traded64.10k
  • 1 Year change-52.77%
  • Beta1.6028
Data delayed at least 15 minutes, as of Aug 19 2019 16:40 BST.
More ▼

Events & Activity

  • AVDL:NMQ price rises above 200-day moving average to 2.25 at 11:44 BST
  • AVDL:NMQ price moved over -5.05% to 1.88
  • AVDL:NMQ price rises above 15-day moving average to 2.16 at 11:03 BST
  • AVDL:NMQ price rises above 15-day moving average to 2.17 at 11:45 BST

Key statistics

As of last trade, Avadel Pharmaceuticals PLC (AVDL:NMQ) traded at 2.22, 115.53% above the 52 week low of 1.03 set on Apr 29, 2019.
52-week range
Today
1.03Apr 29 20195.25Aug 31 2018
Open2.02
High2.29
Low2.02
Bid2.20
Offer2.24
Previous close2.07
Average volume157.27k
Shares outstanding37.45m
Free float35.74m
P/E (TTM)--
Market cap77.52m USD
EPS (TTM)-2.74
USD
Data delayed at least 15 minutes, as of Aug 19 2019 16:40 BST.
More ▼
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.